Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
372.71 Down 2.85(0.76%) Dec 2, 4:00PM EST
|Pre-Market : 372.90 Up 0.19 (0.05%) 5:57PM EST - Nasdaq Real Time Price
Prev Close:375.56
Open:N/A
Bid:370.01 x 100
Ask:393.50 x 100
1y Target Est:450.71
Beta:1.48829
Earnings Date:Feb 7 - Feb 13 (Est.)
Day's Range:N/A - N/A
52wk Range:325.35 - 563.79
Volume:0
Avg Vol (3m):860,559
Market Cap:40.00B
P/E (ttm):54.38
EPS (ttm):6.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.76%40.00B
AMGNUp 1.14%107.13B

Key Statistics

Forward P/E (1 yr):26.08
P/S (ttm):8.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :11.73
Quarterly EPS Est (Dec-16) :3.13
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback